Eli Lilly (LLY) Net Margin Growth (5y) (2014 - 2026)

Eli Lilly (LLY) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,744.00
Mar 31, 2024 -4,670.00
Dec 31, 2023 2,334.00
Sep 30, 2023 -166.00
Jun 30, 2023 2,172.00
Mar 31, 2023 1,831.00
Dec 31, 2022 5,169.00
Sep 30, 2022 1,109.00
Jun 30, 2022 -263.00
Mar 31, 2022 2,648.00
Dec 31, 2021 818.00
Sep 30, 2021 141.00
Jun 30, 2021 679.00
Mar 31, 2021 1,087.00
Mar 31, 2019 5,673.00
Dec 31, 2018 -1,230.00
Sep 30, 2018 -1,979.00
Jun 30, 2018 -2,085.00
Mar 31, 2018 -2,662.00
Dec 31, 2017 -3,889.00